Why Choose Food Research Lab's FRL as Your Food Product Development (FPD) Consultant and Partner?

There are several options in almost every product area in today’s market, and the difficulty is in coming up with unique items that stand out and connect with customers. Food Research Lab's Food Research Lab takes a holistic approach to creating food and beverage products. We define, demographically target, and build effective goods through a sequential process for category selection and comprehension. The client can visit the lab to learn the process. We offer unlimited rounds of revisions to ensure customer satisfaction. The final product prototype, along with the documentation process, including the video (through email), will be shipped to the client, and in case the client is not satisfied with the video, a food technology consultant will visit the place for the product demo at the client’s costs.

What are the different forms that you deliver the Food Product Formulations?

The food industry is witnessing a new form of consumption. Keeping that in mind, we can formulate the products in the form of ready-to-eat, ready-to-drink, ready-to-mix, ready-to-serve, and ready-to-cook food products. We use ingredients that offer an added value to the development and improve its indulgence and sustainability in terms of its functional ingredients, plant-based food dyes, and natural preservatives with a clean label.

What are the sectors Food Research Lab cover?

We cover a wide range of sectors such as soups, sauces and dips, chips, tortillas, dry beverage powder, plant-based products, masalas, puddings, instant mixes and many more.

How is sensory testing been carried out?

Our sensory examination leads to the precise formulation and recipe recommendations. We develop data-driven design models based on sensory research and customer insights. The fact-based design methodology used by Food Research Lab reduces risk and gives our clients market confidence while cutting development time in half. With our dedicated sensory lab facility, our team takes satisfaction in creating and optimizing successful products in the marketplace, generating a favourable return on investment, and developing brand advocates.

Probiotics have gained significant attention due to their potential benefits in treating infectious diseases. Recent systematic review and meta-analyses published in BMC Infectious diseases in 2024, by Nelwan and their co-authors highlights the role of probiotics, both single and multi-strain regimens, as adjuvants to conventional therapies in managing common infections such as Helicobacter pylori, urinary tract infections (UTIs), diarrheal infections, and HIV infections. This meta-analyses discusses findings from a systematic review and meta-analysis that evaluated the effectiveness of probiotics in these areas, summarizing their impact on health outcomes and current evidence gaps.

Role of Probiotics as an Adjuvant in Treating Infections: Evidence-Based Insights

Interesting News . Dec 24, 2024

Probiotics have gained significant attention due to their potential benefits in treating infectious diseases. Recent systematic review and meta-analyses published in BMC Infectious diseases in 2024, by Nelwan and their co-authors highlights the role of probiotics, both single and multi-strain regimens, as adjuvants to conventional therapies in managing common infections such as Helicobacter pylori, urinary tract infections (UTIs), diarrheal infections, and HIV infections. This meta-analyses discusses findings from a systematic review and meta-analysis that evaluated the effectiveness of probiotics in these areas, summarizing their impact on health outcomes and current evidence gaps.

Methodology

The systematic review followed a robust approach, analyzing data from 6,950 studies identified through PubMed, Scopus, Embase, and Cochrane databases. After eliminating duplicates and filtering titles and abstracts, 32 studies were included, comprising:

The data extraction and meta-analysis were conducted using RevMan software, with evidence certainty evaluated through the GRADE system. Bias was assessed using the Cochrane Risk of Bias Tool for Randomized Trials (ROB 1.0 and 2.0).

Key Findings

1. Probiotics in H. pylori Eradication

2. Probiotics in UTIs

3. Probiotics in Diarrheal Infections

4. Probiotics in HIV

The graph highlights the Relative Risk (RR) of probiotics for key conditions:

Conclusion and Future Directions

The analysis supports the use of probiotics as an effective adjuvant in eradicating H. pylori and managing UTIs. Key takeaways include:

Practical Considerations

This evidence-based analysis underscores the growing role of probiotics in treating infections while highlighting areas requiring further investigation. Share your thoughts or ask us about how probiotics can enhance health outcomes